Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs) Meeting Abstract


Authors: Gainor, J. F.; Ravi, A.; Awad, M. M.; Holton, M.; Arniella, M.; Stewart, C.; Freeman, S.; Leshchiner, I.; Chow, A.; Henick, B. S.; Velcheti, V.; Griffin, A. T.; Ricciuti, B.; Riess, J. W.; Janne, P. A.; Hacohen, N.; Wolchok, J. D.; Hellmann, M. D.; Getz, G.
Abstract Title: Clinical characteristics and molecular features of non-small cell lung cancers (NSCLCs) following disease progression on immune checkpoint inhibitors (ICIs)
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680304409
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.e21178
Notes: Meeting Abstract: e21178 -- This meeting was also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Matthew David Hellmann
    412 Hellmann
  3. Andrew Chow
    45 Chow